Covid-19 Vaccine
AstraZeneca accepts cooperation offer from Russian Covid vaccine developers
Moscow/Sputnik: UK-Swedish pharmaceutical company AstraZeneca accepted cooperation offer from developers of Russian coronavirus vaccine Sputnik V to study Covid-19 vaccine combinations, AstraZeneca said Friday.
"Today we announce a clinical trial programme to assess safety and immunogenicity of combination of AZD1222, developed by AstraZeneca and Oxford University and Sputnik V, developed by Russian Gamaleya Research institute. It will begin enrolling adults aged 18 years and older," the UK-Swedish company said.
"The new chapter of vaccine cooperation has started today. We made an offer and AstraZeneca accepted it. It all happened here on Twitter!" the official Twitter account of Russia's Sputnik V vaccine said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
